Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Microbot Medical (MBOT) Capital Expenditures (2016)

Microbot Medical's Capital Expenditures history spans 7 years, with the latest figure at $9566.0 for Q4 2016.

  • For the quarter ending Q4 2016, Capital Expenditures rose 100.95% year-over-year to $9566.0, compared with a TTM value of $25000.0 through Dec 2016, up 1150.0%, and an annual FY2025 reading of $60000.0, up 140.0% over the prior year.
  • Capital Expenditures for Q4 2016 was $9566.0 at Microbot Medical, up from $9500.0 in the prior quarter.
  • The five-year high for Capital Expenditures was $2.3 million in Q2 2013, with the low at -$4.5 million in Q4 2013.
  • Average Capital Expenditures over 5 years is $56211.9, with a median of $100000.0 recorded in 2013.
  • Biggest YoY gain for Capital Expenditures was 94916.73% in 2013; the steepest drop was 8520.0% in 2013.
  • Tracing MBOT's Capital Expenditures over 5 years: stood at $53354.0 in 2012, then tumbled by 8520.0% to -$4.5 million in 2013, then surged by 106.8% to $305511.0 in 2014, then tumbled by 428.39% to -$1.0 million in 2015, then skyrocketed by 100.95% to $9566.0 in 2016.
  • Per Business Quant, the three most recent readings for MBOT's Capital Expenditures are $9566.0 (Q4 2016), $9500.0 (Q2 2016), and $5934.0 (Q1 2016).